---
document_datetime: 2023-09-21 20:03:11
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/lamivudine-teva-epar-all-authorised-presentations_en.pdf
document_name: lamivudine-teva-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.1009779
conversion_datetime: 2025-12-22 13:42:34.93859
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form   | Route of administration   | Immediate Packaging                    | Pack size   |
|------------------|-------------------|------------|-----------------------|---------------------------|----------------------------------------|-------------|
| EU/1/09/566/001  | Lamivudine Teva   | 100 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVdC/alu)                 | 28 tablets  |
| EU/1/09/566/002  | Lamivudine Teva   | 100 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVdC/alu)                 | 30 tablets  |
| EU/1/09/566/003  | Lamivudine Teva   | 100 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVdC/alu)                 | 84 tablets  |
| EU/1/09/566/004  | Lamivudine Teva   | 100 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVdC/alu)                 | 100 tablets |
| EU/1/09/566/005  | Lamivudine Teva   | 100 mg     | Film-coated tablet    | Oral use                  | Bottle (HDPE)                          | 60 tablets  |
| EU/1/09/566/006  | Lamivudine Teva   | 100 mg     | Film-coated tablet    | Oral use                  | Bottle (HDPE with tamper- evident cap) | 60 tablets  |